Daiichi Sankyo Company, Limited 4568.T
Daiichi Sankyo Company, Limited (4568.T) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.74% (safety: moderate). FY2026 revenue was ¥2.12T at a 12.2% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 46 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.314 |
| Retained earnings / assets | 0.387 |
| EBIT / assets | 0.057 |
| Equity / liabilities | 0.711 |
FAQ
Is 4568.T financially healthy?
Daiichi Sankyo Company, Limited's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does 4568.T pay a dividend, and is it safe?
Yes. Daiichi Sankyo Company, Limited pays a dividend yielding about 2.74% with a 49.4% payout ratio, rated “moderate” for safety.
How profitable is 4568.T?
In FY2026, Daiichi Sankyo Company, Limited had a net margin of 12.2% and a return on equity of 15.6%.
Source: company filings via Yahoo Finance · JP · as of 2026-03-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.